Effectiveness of Planning and Management Interventions for Improving Age-appropriate Immunization in Rural India
Overview
Affiliations
Objective: To study the effectiveness of planning and management interventions for ensuring children in India are immunized at the appropriate age.
Methods: The study involved children aged less than 18 months recruited from Haryana, India, in 2005-2006: 4336 in a pre-intervention cohort and 5213 in a post-intervention cohort. In addition, immunization of 814 hospitalized children from outside the study area was also assessed. Operational barriers to age-appropriate immunization with diphtheria, pertussis and tetanus (DPT) vaccine were investigated by monitoring vaccination coverage, observing immunization sessions and interviewing parents and health-care providers. An intervention package was developed, with community volunteers playing a pivotal role. Its effectiveness was assessed by monitoring the ages at which the three DPT doses were administered.
Findings: The main reasons for delayed immunization were staff shortages, non-adherence to plans and vaccine being out of stock. In the post-intervention cohort, 70% received a third DPT dose before the age of 6 months, significantly more than in the pre-intervention cohort (62%; P = 0.002). In addition, the mean age at which the first, second and third DPT doses were administered decreased by 17, 21 and 34 days, respectively, in the study area over a period of 18 months (P for trend < 0.0001). No change was observed in hospitalized children from outside the study area.
Conclusion: An intervention package involving community volunteers significantly improved age-appropriate DPT immunization in India. The Indian Government's intention to recruit village-based volunteers as part of a health sector reform aimed at decentralizing administration could help increase timely immunization.
Interventions for improving coverage of childhood immunisation in low- and middle-income countries.
Oyo-Ita A, Oduwole O, Arikpo D, Effa E, Esu E, Balakrishna Y Cochrane Database Syst Rev. 2023; 12:CD008145.
PMID: 38054505 PMC: 10698843. DOI: 10.1002/14651858.CD008145.pub4.
Wariri O, Okomo U, Kwarshak Y, Utazi C, Murray K, Grundy C PLOS Glob Public Health. 2023; 2(7):e0000325.
PMID: 36962319 PMC: 10021799. DOI: 10.1371/journal.pgph.0000325.
Kim Y BMJ Open. 2021; 11(4):e045070.
PMID: 33853801 PMC: 8054109. DOI: 10.1136/bmjopen-2020-045070.
Gunning C, Mwananyanda L, MacLeod W, Mwale M, Thea D, Pieciak R BMJ Open. 2021; 10(12):e041198.
PMID: 33384391 PMC: 7780521. DOI: 10.1136/bmjopen-2020-041198.
Beauregard M, Brousseau N, Ouakki M, Kiely M, Sauvageau C, Clement P Hum Vaccin Immunother. 2020; 16(12):3170-3176.
PMID: 32429743 PMC: 8641605. DOI: 10.1080/21645515.2020.1748980.